M&T Bank Corp Sells 1,004 Shares of HCA Healthcare, Inc. (NYSE:HCA)

M&T Bank Corp trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA) by 7.9% in the third quarter, HoldingsChannel.com reports. The firm owned 11,734 shares of the company’s stock after selling 1,004 shares during the period. M&T Bank Corp’s holdings in HCA Healthcare were worth $4,769,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. FMR LLC increased its position in HCA Healthcare by 322.3% during the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after purchasing an additional 2,397,883 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in HCA Healthcare by 2.8% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock valued at $604,511,000 after buying an additional 41,190 shares during the period. Janus Henderson Group PLC grew its holdings in HCA Healthcare by 12.0% during the 3rd quarter. Janus Henderson Group PLC now owns 1,339,638 shares of the company’s stock worth $544,467,000 after acquiring an additional 143,995 shares during the period. Darsana Capital Partners LP boosted its position in shares of HCA Healthcare by 53.3% during the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after purchasing an additional 400,000 shares in the last quarter. Finally, TD Asset Management Inc lifted its stake in HCA Healthcare by 2.7% in the second quarter. TD Asset Management Inc now owns 741,130 shares of the company’s stock valued at $238,110,000 after buying an additional 19,812 shares during the period. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA opened at $312.00 on Friday. The company has a market capitalization of $79.03 billion, a price-to-earnings ratio of 14.15, a PEG ratio of 1.23 and a beta of 1.63. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The stock has a 50 day moving average of $358.55 and a 200 day moving average of $358.60. HCA Healthcare, Inc. has a 12 month low of $261.31 and a 12 month high of $417.14.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.85%. HCA Healthcare’s payout ratio is currently 11.85%.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Royal Bank of Canada boosted their target price on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their price objective for the company from $400.00 to $320.00 in a report on Monday, November 25th. Truist Financial boosted their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $387.13.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.